EUVIMEDEUVIMED entdecken
Open Access

Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer

Taro Sakamoto, Takeshi Gocho, Masashi Tsunematsu, Yoshihiro Shirai, Norimitsu Okui, Ryoga Hamura, Yoshiaki Tanji, Takashi Aida, Yuta Yamada, Kohei Okazaki, Yuto Yamahata, Kenei Furukawa und 1 weitere

Cancer Diagnosis & Prognosis · 01.11.2026 · 6 (6) · 977-987

DOI: 10.21873/cdp.10600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.11.2026. Verfasst von Taro Sakamoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: Although lymph node metastasis is a negative prognostic factor in pancreatic cancer, the significance of non-metastatic lymph node enlargement remains unclear. This study evaluated the prognostic impact of the No. 8 lymph node (N8LN), which is routinely assessed during pancreaticoduodenectomy and identifiable on preoperative imaging. Patients and Methods: We retrospectively reviewed 99 patients who underwent pancreaticoduodenectomy for pancreatic cancer between 2009 and 2019. The size of the N8LN was measured on preoperative imaging, and patients were divided into small and large groups based on the median value. Long-term oncologic outcomes were compared between the two groups. To assess the local immune response, CD8 immunohistochemistry was performed on nodal sections, and CD8⁺ T-cell density was quantified using QuPath software.

Results

The large group showed significantly longer progression-free survival (19.7 vs. 9.4 months) and disease-specific survival (41.7 vs. 17.1 months) than the small group. Enlarged N8LN remained an independent favorable prognostic factor in multivariable analysis. CD8⁺ T-cell density did not differ between groups.

Conclusion

Enlarged N8LN size was independently associated with better survival after pancreaticoduodenectomy. Nodal enlargement may reflect host immune activity rather than tumor progression and merits further investigation.

Schlagwörter

Stichwörter der Autor:innen

Pancreatic cancerhost immunitylymph nodepancreaticoduodenectomyprognosis

Autor:innen und Institutionen

  • Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Zitieren

APA

Sakamoto, T., Gocho, T., Tsunematsu, M., Shirai, Y., Okui, N., Hamura, R., Tanji, Y., Aida, T., Yamada, Y., Okazaki, K., Yamahata, Y., Furukawa, K., & Ikegami, T. (2026). Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer. Cancer Diagnosis & Prognosis, 6(6), 977-987. https://doi.org/10.21873/cdp.10600

Vancouver

Sakamoto T, Gocho T, Tsunematsu M, Shirai Y, Okui N, Hamura R, et al. Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer. Cancer Diagnosis & Prognosis. 2026;6(6):977-987. doi:10.21873/cdp.10600

BibTeX
@article{Sakamoto2026,
  author = {Sakamoto, Taro and Gocho, Takeshi and Tsunematsu, Masashi and Shirai, Yoshihiro and Okui, Norimitsu and Hamura, Ryoga and Tanji, Yoshiaki and Aida, Takashi and Yamada, Yuta and Okazaki, Kohei and Yamahata, Yuto and Furukawa, Kenei and Ikegami, Toru},
  title = {Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer},
  journal = {Cancer Diagnosis & Prognosis},
  year = {2026},
  volume = {6},
  number = {6},
  pages = {977--987},
  doi = {10.21873/cdp.10600}
}
Kostenlos starten →